Journals and Databases

Start a new search

Healthcare Databases Advanced Search | Help

 

Searched: Antiretroviral Therapy, Highly Active. Total records matched: 3098

Resources searched: MEDLINE from PubMed

  1. 1. Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy (HAART).

    Author(s): Viswanathan S, Justice AC, Alexander GC, Brown TT, Gandhi NR, McNicholl IR, Rimland D, Rodriguez-Barradas MC, Jacobson LP

    Citation: Journal of acquired immune deficiency syndromes (1999), 13 April 2015, 1525-4135

    Publication Date: 13 April 2015

    Source: MEDLINE from PubMed

  2. 2. Cardiac Function in Vertically HIV-infected Children and Adolescents in the Era of Highly Active Antiretroviral Therapy.

    Author(s): Sainz T, Álvarez-Fuente M, Fernández-Jiménez R, González-Tomé MI, de José MI, Ramos JT, Navarro ML, Martínez J, García-Hortelano M, Medrano C, Muñoz-Fernández MÁ, Mellado MJ

    Citation: The Pediatric infectious disease journal, May 2015, vol./is. 34/5(e125-31), 0891-3668

    Publication Date: May 2015

    Source: MEDLINE from PubMed

  3. 3. Characteristics and Outcomes of HIV-Infected Patients With Severe Sepsis: Continued Risk in the Post-Highly Active Antiretroviral Therapy Era.

    Author(s): Cribbs SK, Tse C, Andrews J, Shenvi N, Martin GS

    Citation: Critical care medicine, 06 April 2015, 0090-3493

    Publication Date: 06 April 2015

    Source: MEDLINE from PubMed

  4. 4. Resolution of dilated cardiomyopathy in an adolescent with change of a failing highly active antiretroviral drug therapy.

    Author(s): Aliku TO, Lubega S, Lwabi P

    Citation: African health sciences, March 2015, vol./is. 15/1(288-92), 1680-6905

    Publication Date: March 2015

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

  5. 5. Adherence to highly active antiretroviral therapy impact on clinical and economic outcomes for Medicaid enrollees with human immunodeficiency virus and hepatitis C coinfection.

    Author(s): Zhang S, Rust G, Cardarelli K, Felizzola J, Fransua M, Stringer HG Jr

    Citation: AIDS care, July 2015, vol./is. 27/7(829-35), 0954-0121

    Publication Date: July 2015

    Source: MEDLINE from PubMed

  6. 6. Safety and Effectiveness of Highly Active Antiretroviral Therapy in Treatment-Naïve HIV Patients: Preliminary Findings of a Cohort Event Monitoring Study in Belarus.

    Author(s): Setkina S, Dotsenko M, Bondar S, Charnysh I, Kuchko A, Kaznacheeva A, Kozorez E, Dodaleva A, Rossa N

    Citation: Drug safety, 26 March 2015, 0114-5916

    Publication Date: 26 March 2015

    Source: MEDLINE from PubMed

  7. 7. Adherence to highly active antiretroviral therapy in Hyderabad, India: barriers, facilitators and identification of target groups.

    Author(s): Dworkin MS, Douglas GW, Rani GS, Chakraborty A

    Citation: International journal of STD & AIDS, 22 March 2015, 0956-4624

    Publication Date: 22 March 2015

    Source: MEDLINE from PubMed

  8. 8. Effect of co-morbidities on disease course in human immunodeficiency virus-infected illicit drug users in the era of highly active antiretroviral therapy.

    Author(s): Kandi V

    Citation: Epidemiology and health, 2015(e2015008),

    Publication Date: 2015

    Source: MEDLINE from PubMed

  9. 9. Assessment of adherence to highly active antiretroviral therapy and associated factors among people living with HIV at Debrebrihan Referral Hospital and Health Center, Northeast Ethiopia: a cross-sectional study.

    Author(s): Ketema AK, Shewangizaw Weret Z

    Citation: HIV/AIDS (Auckland, N.Z.), 2015(75-81),

    Publication Date: 2015

    Source: MEDLINE from PubMed

  10. 10. Total Lymphocyte Count and Haemoglobin Concentration Combined as a Surrogate Marker for Initiating Highly Active Antiretroviral Therapy in a Resource-limited Setting as against CD4 Cell Count.

    Author(s): Dhamangaonkar AC, Mathew A, Pazare AR

    Citation: The West Indian medical journal, 08 May 2014, vol./is. 63/5, 0043-3144

    Publication Date: 08 May 2014

    Source: MEDLINE from PubMed

  11. 11. Impact of Gender on Long-Term Treatment Outcomes of Highly Active Antiretroviral Therapy (HAART) in the TREAT Asia HIV Observational Database.

    Author(s): Lee MP, Zhou J, Messerschmidt L, Honda M, Ditangco R, Sirisanthana T, Kumarasamy N, Phanuphak P, Chen YM, Zhang F, Saphonn V, Kiertiburanakul S, Lee CK, Pujari S, Choi JY, Kamarulzaman A, Yunihastuti E, Merati TP, Lim PL, Li PC

    Citation: AIDS patient care and STDs, 16 March 2015, 1087-2914

    Publication Date: 16 March 2015

    Source: MEDLINE from PubMed

  12. 12. ANNALS EXPRESS: Cystatin C and creatinine based equations in the assessment of renal function in HIV positive patients prior to commencing Highly Active Antiretroviral Therapy (HAART).

    Author(s): Seape T, Gounden V, van Deventer HE, Candy G, George JA

    Citation: Annals of clinical biochemistry, 12 March 2015, 0004-5632

    Publication Date: 12 March 2015

    Source: MEDLINE from PubMed

  13. 13. Effect of HIV Infection and Highly Active Antiretroviral Therapy on Hearing Function: A Prospective Case-Control Study From Cameroon.

    Author(s): Fokouo JV, Vokwely JE, Noubiap JJ, Nouthe BE, Zafack J, Minka Ngom ES, Dalil AB, Ngo Nyeki AR, Bengono G, Njock R

    Citation: JAMA otolaryngology-- head & neck surgery, 05 March 2015, 2168-6181

    Publication Date: 05 March 2015

    Source: MEDLINE from PubMed

  14. 14. Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation.

    Author(s): Maggiolo F, Colombo GL, Di Matteo S, Bruno GM, Astuti N, Di Filippo E, Masini G, Bernardini C

    Citation: Patient related outcome measures, 2015(53-60),

    Publication Date: 2015

    Source: MEDLINE from PubMed

  15. 15. Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, Canada.

    Author(s): Lourenço L, Samji H, Nohpal A, Chau W, Colley G, Lepik K, Barrios R, Lima V, Hogg R, Montaner J, Kesselring S, Moore D

    Citation: HIV medicine, 27 February 2015, 1464-2662

    Publication Date: 27 February 2015

    Source: MEDLINE from PubMed

  16. 16. Thymic function over one-year highly active antiretroviral therapy (HAART) in HIV-infected Thai patients with different immune recovery.

    Author(s): Kingkeow D, Srithep S, Praparattanapan J, Supparatpinyo K, Pornprasert S

    Citation: Japanese journal of infectious diseases, 13 February 2015, 1344-6304

    Publication Date: 13 February 2015

    Source: MEDLINE from PubMed

  17. 17. Fibrinolytic changes in pregnant women on highly active antiretroviral therapy.

    Author(s): Osime OE, Ese-Onakewhor JU, Kolade SO

    Citation: Saudi medical journal, February 2015, vol./is. 36/2(200-3), 0379-5284

    Publication Date: February 2015

    Source: MEDLINE from PubMed

  18. 18. The effect of highly active antiretroviral therapy on the prevalence of oral manifestation in human immunodeficiency virus-infected patients in Karnataka, India.

    Author(s): Patil N, Chaurasia VR, Babaji P, Ramesh D, Jhamb K, Sharma AM

    Citation: European journal of dentistry, January 2015, vol./is. 9/1(47-52), 1305-7456

    Publication Date: January 2015

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

  19. 19. CD4 Count is Still a Valid Indicator of Outcome in HIV-Infected Patients Undergoing Major Abdominal Surgery in the Era of Highly Active Antiretroviral Therapy.

    Author(s): Chichom-Mefire A, Azabji-Kenfack M, Atashili J

    Citation: World journal of surgery, 07 February 2015, 0364-2313

    Publication Date: 07 February 2015

    Source: MEDLINE from PubMed

  20. 20. CLEFT PALATE IN HIV-EXPOSED NEWBORNS OF MOTHERS ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY.

    Author(s): James A, Oluwatosin B, Njideka G, Babafemi, Benjamin OG, Olufemi D, Leo R, Folorunso I, Phylis, Olusina O

    Citation: Oral surgery, December 2014, vol./is. 7/Suppl 1(102-106), 1752-2471

    Publication Date: December 2014

    Source: MEDLINE from PubMed

  21. 21. Adherence to highly active antiretroviral therapy (HAART) in HIV/AIDS patient.

    Author(s): Nelwan EJ

    Citation: Acta medica Indonesiana, October 2014, vol./is. 46/4(273-4), 0125-9326

    Publication Date: October 2014

    Source: MEDLINE from PubMed

  22. 22. Gender differences in health related quality of life among people living with HIV on highly active antiretroviral therapy in Mekelle Town, Northern Ethiopia.

    Author(s): Tesfay A, Gebremariam A, Gerbaba M, Abrha H

    Citation: BioMed research international, 2015(516369), 2314-6133

    Publication Date: 2015

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at ProQuest

    Available in fulltext at EBSCOhost

  23. 23. [Epidemiological characteristics of HIV/AIDS patients newly received highly active antiretroviral therapy during 2005-2013 in Jiangsu province].

    Author(s): Qiu T, Ding P, Liu X, Xu J, Guo H, Fu G, Xu X, Huan X

    Citation: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, December 2014, vol./is. 35/12(1320-3), 0254-6450

    Publication Date: December 2014

    Source: MEDLINE from PubMed

  24. 24. Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study.

    Author(s): Katz IT, Leister E, Kacanek D, Hughes MD, Bardeguez A, Livingston E, Stek A, Shapiro DE, Tuomala R

    Citation: Annals of internal medicine, 20 January 2015, vol./is. 162/2(90-9), 0003-4819

    Publication Date: 20 January 2015

    Source: MEDLINE from PubMed

  25. 25. Clinical challenges of thyroid eye disease in HIV-positive patients on highly active antiretroviral therapy.

    Author(s): Edmunds MR, Mellington F, Ford RL, Torlinska B, Manavi K, Boelaert K

    Citation: The Journal of clinical endocrinology and metabolism, March 2015, vol./is. 100/3(779-87), 0021-972X

    Publication Date: March 2015

    Source: MEDLINE from PubMed

  26. 26. [Analysis of the five-year effectiveness of highly active antiretroviral therapy among 200 HIV/AIDS patients in Jiangsu province].

    Author(s): Qiu T, Ding P, Liu X, Guo H, Fu G, Xu X, Huan X, Yang H

    Citation: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine], November 2014, vol./is. 48/11(947-52), 0253-9624

    Publication Date: November 2014

    Source: MEDLINE from PubMed

  27. 27. Associated factors of drug-drug interactions of highly active antiretroviral therapy: report from a referral center.

    Author(s): Farhoudi M, Khalili H, Karimzadeh I, Abbasian L

    Citation: Expert opinion on drug metabolism & toxicology, April 2015, vol./is. 11/4(471-9), 1742-5255

    Publication Date: April 2015

    Source: MEDLINE from PubMed

  28. 28. Outcome of highly active antiretroviral therapy in HIV- infected Indian children.

    Author(s): Mukherjee A, Shah N, Singh R, Vajpayee M, Kabra SK, Lodha R

    Citation: BMC infectious diseases, 24 December 2014, vol./is. 14/1(2),

    Publication Date: 24 December 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

    Available in fulltext at BioMedCentral

    Available in fulltext at ProQuest

  29. 29. Highly-active antiretroviral therapy and oral opportunistic microorganisms in HIV-positive individuals of Thailand.

    Author(s): Arirachakaran P, Poovorawan Y, Dahlén G

    Citation: Journal of investigative and clinical dentistry, 24 December 2014, 2041-1618

    Publication Date: 24 December 2014

    Source: MEDLINE from PubMed

  30. 30. The effect of depressive symptoms and CD4 count on adherence to highly active antiretroviral therapy in sub-Saharan Africa.

    Author(s): Memiah P, Shumba C, Etienne-Mesubi M, Agbor S, Hossain MB, Komba P, Niyang M, Biadgilign S

    Citation: Journal of the International Association of Providers of AIDS Care, July 2014, vol./is. 13/4(346-52), 2325-9574

    Publication Date: July 2014

    Source: MEDLINE from PubMed

  31. 31. Retraction: effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women.

    Citation: BMC research notes, 25 November 2014(868),

    Publication Date: 25 November 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

    Available in fulltext at BioMedCentral

    Available in fulltext at ProQuest

  32. 32. Inter and intra-host variability of hepatitis C virus genotype 1a hypervariable envelope coding domains followed for a 4-11 year of human immunodeficiency virus coinfection and highly active antiretroviral therapy.

    Author(s): Sede M, Jones LR, Moretti F, Laufer N, Quarleri J

    Citation: Virology, December 2014(19-28), 0042-6822

    Publication Date: December 2014

    Source: MEDLINE from PubMed

  33. 33. Cardiac steatosis and left ventricular dysfunction in HIV-infected patients treated with highly active antiretroviral therapy.

    Author(s): Nelson MD, Szczepaniak LS, LaBounty TM, Szczepaniak E, Li D, Tighiouart M, Li Q, Dharmakumar R, Sannes G, Fan Z, Yumul R, Hardy WD, Hernandez Conte A

    Citation: JACC. Cardiovascular imaging, November 2014, vol./is. 7/11(1175-7), 1936-878X

    Publication Date: November 2014

    Source: MEDLINE from PubMed

  34. 34. Highly active antiretroviral therapy-related hepatotoxicity in human immunodeficiency virus and hepatitis C virus co-infected patients with advanced liver fibrosis in Taiwan.

    Author(s): Chou CC, Tsai HC, Wu KS, Sy CL, Chen JK, Chen YS, Lee SS

    Citation: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 01 November 2014, 1684-1182

    Publication Date: 01 November 2014

    Source: MEDLINE from PubMed

  35. 35. Efficacy of Generic Highly Active Antiretroviral Therapy in HIV-1 Infected Individuals in Nigeria.

    Author(s): Adewumi OM, Odaibo GN, Olaleye OD

    Citation: Journal of immunoassay & immunochemistry, 2015, vol./is. 36/5(464-77), 1532-1819

    Publication Date: 2015

    Source: MEDLINE from PubMed

  36. 36. HIV-1 Subtype Diversity Based on Envelope C2V3 Sequences from Kenyan Patients on Highly Active Antiretroviral Therapy.

    Author(s): Kitawi RC, Nzomo T, Mwatelah RS, Aman R, Kimulwo MJ, Masankwa G, Lwembe RM, Okendo J, Ogutu B, Ochieng W

    Citation: AIDS research and human retroviruses, April 2015, vol./is. 31/4(452-5), 0889-2229

    Publication Date: April 2015

    Source: MEDLINE from PubMed

  37. 37. HIV reservoir dynamics in the face of highly active antiretroviral therapy.

    Author(s): Costiniuk CT, Jenabian MA

    Citation: AIDS patient care and STDs, February 2015, vol./is. 29/2(55-68), 1087-2914

    Publication Date: February 2015

    Source: MEDLINE from PubMed

  38. 38. Short communication: Apoptosis pathways in HIV-1-infected patients before and after highly active antiretroviral therapy: relevance to immune recovery.

    Author(s): Pitrak DL, Novak RM, Estes R, Tschampa J, Abaya CD, Martinson J, Bradley K, Tenorio AR, Landay AL

    Citation: AIDS research and human retroviruses, February 2015, vol./is. 31/2(208-16), 0889-2229

    Publication Date: February 2015

    Source: MEDLINE from PubMed

  39. 39. Erectile Dysfunction Among HIV Patients Undergoing Highly Active Antiretroviral Therapy: Dyslipidemia as a Main Risk Factor.

    Author(s): Romero-Velez G, Lisker-Cervantes A, Villeda-Sandoval CI, Sotomayor de Zavaleta M, Olvera-Posada D, Sierra-Madero JG, Arreguin-Camacho LO, Castillejos-Molina RA

    Citation: Sexual medicine, April 2014, vol./is. 2/1(24-30),

    Publication Date: April 2014

    Source: MEDLINE from PubMed

  40. 40. Basis of selection of first and second line highly active antiretroviral therapy for HIV/AIDS on genetic barrier to resistance: a literature review.

    Author(s): Katusiime C, Ocama P, Kambugu A

    Citation: African health sciences, September 2014, vol./is. 14/3(679-81), 1680-6905

    Publication Date: September 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

  41. 41. Level of Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy (HAART).

    Author(s): Viswanathan S, Detels R, Mehta SH, Macatangay BJ, Kirk GD, Jacobson LP

    Citation: AIDS and behavior, April 2015, vol./is. 19/4(601-11), 1090-7165

    Publication Date: April 2015

    Source: MEDLINE from PubMed

  42. 42. The impact of comorbid clinical depression on the health-related quality of life of adults on highly active antiretroviral therapy in maiduguri, northeastern Nigeria.

    Author(s): Wakawa IA, Said JM, Abba WM, Shehu S, Rabbebe IB, Beida O

    Citation: Indian journal of psychological medicine, October 2014, vol./is. 36/4(408-17), 0253-7176

    Publication Date: October 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at ProQuest

  43. 43. Prevalence of anemia before and after initiation of highly active antiretroviral therapy among HIV positive patients in Northwest Ethiopia: a retrospective study.

    Author(s): Tesfaye Z, Enawgaw B

    Citation: BMC research notes, 22 October 2014(745),

    Publication Date: 22 October 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

    Available in fulltext at BioMedCentral

    Available in fulltext at ProQuest

  44. 44. Lipodystrophy syndrome among HIV infected children on highly active antiretroviral therapy in northern India.

    Author(s): Bhutia E, Hemal A, Yadav TP, Ramesh KL

    Citation: African health sciences, June 2014, vol./is. 14/2(408-13), 1680-6905

    Publication Date: June 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

  45. 45. Atherogenic index of plasma in highly active antiretroviral therapy-naïve patients with human immunodeficiency virus infection in Southeast Nigeria.

    Author(s): Onyedum CC, Young EE, Iroezindu MO, Chukwuka CJ, Nwagha UI

    Citation: Indian journal of endocrinology and metabolism, September 2014, vol./is. 18/5(631-6), 2230-8210

    Publication Date: September 2014

    Source: MEDLINE from PubMed

  46. 46. Influence of highly-active antiretroviral therapy on the subgingival biofilm in HIV-infected patients.

    Author(s): Jordan RA, Lucaciu A, Zimmer S

    Citation: Journal of investigative and clinical dentistry, 06 October 2014, 2041-1618

    Publication Date: 06 October 2014

    Source: MEDLINE from PubMed

  47. 47. Glycaemic profile changes by highly active antiretroviral therapy in human immunodeficiency virus-infected patients.

    Author(s): Duro M, Rebelo I, Barreira S, Sarmento-Castro R, Medeiros R, Almeida C

    Citation: International journal of STD & AIDS, 02 October 2014, 0956-4624

    Publication Date: 02 October 2014

    Source: MEDLINE from PubMed

  48. 48. Multicentric Castleman's Disease and Kaposi's Sarcoma in a HIV-Positive Patient on Highly Active Antiretroviral Therapy.

    Author(s): Ortega L, Cooper CJ, Otoukesh S, Mojtahedzadeh M, Didia CS, Torabi A, Nahleh Z

    Citation: Rare tumors, 30 July 2014, vol./is. 6/3(5480), 2036-3605

    Publication Date: 30 July 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

  49. 49. Stimulant use and progression to AIDS or mortality after the initiation of highly active antiretroviral therapy.

    Author(s): Carrico AW, Shoptaw S, Cox C, Stall R, Li X, Ostrow DG, Vlahov D, Plankey MW

    Citation: Journal of acquired immune deficiency syndromes (1999), 15 December 2014, vol./is. 67/5(508-13), 1525-4135

    Publication Date: 15 December 2014

    Source: MEDLINE from PubMed

  50. 50. Selected micronutrient levels and response to highly active antiretroviral therapy (HAART) among HIV/AIDS patients attending a teaching Hospital in Addis Ababa, Ethiopia.

    Author(s): Eshetu A, Tsegaye A, Petros B

    Citation: Biological trace element research, December 2014, vol./is. 162/1-3(106-12), 0163-4984

    Publication Date: December 2014

    Source: MEDLINE from PubMed


Results Selected
No results selected.

Output Format
Choose output document format.
Display Format
Choose output fields.
Actions
Display, save or email results with selected fields and output formats.